GLP-1 Weight Loss Drugs: Semaglutide vs Ozempic Explained
The Evolution of GLP-1 Receptor Agonists in Contemporary Weight Management The advent of glucagon-like peptide-1 (GLP-1) receptor agonists has revolutionized pharmacological approaches to obesity and metabolic syndrome. Notably, Semaglutide and its branded form Ozempic have emerged as predominant agents, leveraging their incretin-mimetic mechanisms to facilitate weight loss through appetite suppression and improved glycemic control. Their … Read more